CoChat

Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations

Open access
Huang, Lei, Jansen, Lina, Balavarca, Yesilda, Molina-Montes, Esther, Babaei, Masoud, van der Geest, Lydia, Lemmens, Valery, Van Eycken, Liesbet, De Schutter, Harlinde, Johannesen, Tom B, Fristrup, Claus W, Mortensen, Michael B, Primic-Žakelj, Maja, Zadnik, Vesna, Becker, Nikolaus, Hackert, Thilo, Mägi, Margit, Cassetti, Tiziana, Sassatelli, Romano, Grützmann, Robert, Merkel, Susanne, Gonçalves, Ana F, Bento, Maria J, Hegyi, Péter, Lakatos, Gábor, Szentesi, Andrea, Moreau, Michel, van de Velde, Tony, Broeks, Annegien, Sant, Milena, Minicozzi, Pamela, Mazzaferro, Vincenzo, Real, Francisco X, Carrato, Alfredo, Molero, Xavier, Besselink, Marc G, Malats, Núria, Büchler, Markus W, Schrotz-King, Petra, Brenner, Hermann · 2019 · Gut
Cited by 223

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objective: Resection can potentially cure resectable pancreatic cancer (PaC) and significantly prolong survival in some patients. This large-scale international study aimed to investigate variations in resection for PaC in Europe and USA and determinants for its utilisation. Design: Data from six European population-based cancer registries and the US Surveillance, Epidemiology, and End Results Program database during 2003–2016 were analysed. Age-standardised resection rates for overall and stage I–II PaCs were computed. Associations between resection and demographic and clinical parameters were assessed using multivariable logistic regression models. Results: A total of 153 698 records were analysed. In population-based registries in 2012–2014, resection rates ranged from 13.2% (Estonia) to 21.2% (Slovenia) overall and from 34.8% (Norway) to 68.7% (Denmark) for stage I–II tumours, with great international variations. During 2003–2014, resection rates only increased in USA, the Netherlands and Denmark. Resection was significantly less frequently performed with more advanced tumour stage (ORs for stage III and IV versus stage I–II tumours: 0.05–0.18 and 0.01–0.06 across countries) and increasing age (ORs for patients 70–79 and ≥80 versus those <60 years: 0.37–0.63 and 0.03–0.16 across countries). Patients with advanced-stage tumours (stage III–IV: 63.8%–81.2%) and at older ages (≥70 years: 52.6%–59.5%) receiving less frequently resection comprised the majority of diagnosed cases. Patient performance status, tumour location and size were also associated with resection application. Conclusion: Rates of PaC resection remain low in Europe and USA with great international variations. Further studies are warranted to explore reasons for these variations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2017-314828

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 43

  1. 10.3322/caac.21262 · DOI · Paper page
  2. 10.1093/annonc/mdw022 · DOI · Paper page
  3. 10.3322/caac.21190 · DOI · Paper page
  4. 10.1093/annonc/mdv295 · DOI · Paper page
  5. 10.6004/jnccn.2014.0106 · DOI · Paper page
  6. 10.1200/JCO.2016.67.1412 · DOI · Paper page
  7. 10.1200/JCO.2016.67.5553 · DOI · Paper page
  8. 10.1200/JCO.2016.67.5561 · DOI · Paper page
  9. 10.1001/jama.2013.279201 · DOI · Paper page
  10. Nimptsch, 2016, Nationwide in-hospital mortality following pancreatic surgery in Germany is higher than anticipated, Ann Surg, 264, 1082, 10.1097/SLA.0000000000001693 · DOI
  11. Krautz C , Nimptsch U , Weber GF , et al . Effect of Hospital Volume on In-hospital Morbidity and Mortality Following Pancreatic Surgery in Germany. Ann Surg 2017:1.doi:10.1097/SLA.0000000000002248 · DOI · Paper page
  12. Ceppa, 2015, Reducing readmissions after pancreatectomy: limiting complications and coordinating the care continuum, J Am Coll Surg, 221, 708, 10.1016/j.jamcollsurg.2015.05.012 · doi:10.1016/j.jamcollsurg.2015.05.012
  13. 10.1002/bjs.8664 · DOI · Paper page
  14. 10.1002/bjs.7581 · DOI
  15. 10.1002/bjs.9468 · DOI · Paper page
  16. van der Geest, 2016, Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands, Acta Oncol, 55, 278, 10.3109/0284186X.2015.1105381 · doi:10.3109/0284186x.2015.1105381
  17. Cronin-Fenton, 2011, Pancreatic cancer survival in central and northern Denmark from 1998 through 2009: a population-based cohort study, Clin Epidemiol, 3, 19, 10.2147/CLEP.S20611 · DOI
  18. Onete, 2015, Impact of centralization of pancreatoduodenectomy on reported radical resections rates in a nationwide pathology database, HPB, 17, 736, 10.1111/hpb.12425 · DOI
  19. van der Geest, 2016, Volume-outcome relationships in pancreatoduodenectomy for cancer, HPB, 18, 317, 10.1016/j.hpb.2016.01.515 · DOI
  20. 10.1245/s10434-010-1511-4 · DOI
  21. O’Mahoney, 2016, Centralization of pancreatoduodenectomy a decade later: Impact of the volume-outcome relationship, Surgery, 159, 1528, 10.1016/j.surg.2016.01.008 · doi:10.1016/j.surg.2016.01.008
  22. Ryan, 2015, Pancreaticoduodenectomy in Florida: do 20-year trends document the salutary benefits of centralization of care?, HPB, 17, 832, 10.1111/hpb.12467 · doi:10.1111/hpb.12467
  23. 10.1002/bjs.5861 · doi:10.1002/bjs.5861
  24. Ahola, 2017, Effect of centralization on long-term survival after resection of pancreatic ductal adenocarcinoma, Br J Surg, 104, 1532, 10.1002/bjs.10560 · doi:10.1002/bjs.10560
  25. 10.1007/s00268-013-2108-4 · DOI
  26. 10.1245/s10434-014-4036-4 · DOI · Paper page
  27. Kim, 2016, Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma, HPB, 18, 325, 10.1016/j.hpb.2015.10.014 · doi:10.1016/j.hpb.2015.10.014
  28. 10.1016/S1470-2045(13)70172-4 · DOI · Paper page
  29. 10.1245/s10434-013-2886-9 · DOI · Paper page
  30. 10.1016/j.surg.2014.02.001 · DOI · Paper page
  31. 10.6004/jnccn.2017.0131 · DOI · Paper page
  32. 10.1097/SLA.0000000000000263 · DOI · Paper page
  33. Sukharamwala, 2012, Advanced age is a risk factor for post-operative complications and mortality after a pancreaticoduodenectomy: a meta-analysis and systematic review, HPB, 14, 649, 10.1111/j.1477-2574.2012.00506.x · DOI · Paper page
  34. He, 2015, Underuse of surgical resection among elderly patients with early-stage pancreatic cancer, Surgery, 158, 1226, 10.1016/j.surg.2015.04.031 · doi:10.1016/j.surg.2015.04.031
  35. Marmor, 2016, A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas, Cancer, 122, 3378, 10.1002/cncr.30199 · doi:10.1002/cncr.30199
  36. 10.1111/j.1532-5415.2011.03785.x · doi:10.1111/j.1532-5415.2011.03785.x
  37. 10.1001/archsurg.2011.294 · DOI
  38. Cameron, 2015, Two thousand consecutive pancreaticoduodenectomies, J Am Coll Surg, 220, 530, 10.1016/j.jamcollsurg.2014.12.031 · DOI · Paper page
  39. Heerkens, 2016, Health-related quality of life after pancreatic resection for malignancy, Br J Surg, 103, 257, 10.1002/bjs.10032 · DOI
  40. Laitinen, 2017, Quality of life in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy, Pancreatology, 17, 445, 10.1016/j.pan.2017.02.013 · doi:10.1016/j.pan.2017.02.013
  41. 10.1093/annonc/mdt193 · DOI
  42. Minicozzi, 2017, Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study, Eur J Cancer, 84, 335, 10.1016/j.ejca.2017.07.015 · doi:10.1016/j.ejca.2017.07.015
  43. van Rijssen, 2016, National compliance to an evidence-based multidisciplinary guideline on pancreatic and periampullary carcinoma, Pancreatology, 16, 133, 10.1016/j.pan.2015.10.002 · doi:10.1016/j.pan.2015.10.002

Cited by

See all 223

Metadata

Authors
Huang, L., Jansen, L., Balavarca, Y., Molina-Montes, E., Babaei, M., van der Geest, L., Lemmens, V., Van Eycken, L., De Schutter, H., Johannesen, T. B., Fristrup, C. W., Mortensen, M. B., Primic-Žakelj, M., Zadnik, V., Becker, N., Hackert, T., Mägi, M., Cassetti, T., Sassatelli, R., Grützmann, R., Merkel, S., Gonçalves, A. F., Bento, M. J., Hegyi, P., Lakatos, G., Szentesi, A., Moreau, M., van de Velde, T., Broeks, A., Sant, M., Minicozzi, P., Mazzaferro, V., Real, F. X., Carrato, A., Molero, X., Besselink, M. G., Malats, N., Büchler, M. W., Schrotz-King, P., & Brenner, H.
Venue
Gut
Publisher
BMJ
Published
2017-11-20
Volume
68
Issue
1
Pages
130-139
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2770675262
Cited by
223
References
4
FWCI
6.35
Type
journal article
Language
en
Open access
green
Funders
  • Deutsche Krebshilfe
  • Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III-FEDER, Spain
  • European Cooperation in Science and Technology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. https://app.cochat.ai/papers/10.1136/gutjnl-2017-314828
The paper
Huang, L., Jansen, L., Balavarca, Y., Molina-Montes, E., Babaei, M., van der Geest, L., Lemmens, V., Van Eycken, L., De Schutter, H., Johannesen, T. B., Fristrup, C. W., Mortensen, M. B., Primic-Žakelj, M., Zadnik, V., Becker, N., Hackert, T., Mägi, M., Cassetti, T., Sassatelli, R., . . . Brenner, H. (2019). Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. Gut. https://doi.org/10.1136/gutjnl-2017-314828

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.